Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Mathieu

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
The French Journal of Urology|October 11, 2025
Understanding management strategies for metastatic hormone-sensitive prostate cancer: A multidisciplinary survey in FranceAurélien Gobert, Marc-Olivier Timsit, Pierre Blanchard, et al.
The French Journal of Urology|July 7, 2026
Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological AssociationMichael Baboudjian, Eric Barret, Laurent Brureau, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Anthony Chapron, Marie-Astrid Metten, Arnaud Maury, et al.
Journal of Clinical Medicine|January 11, 2022
Overview of the Development and Use of Akt Inhibitors in Prostate CancerAnis Gasmi, Guilhem Roubaud, Charles Dariane, et al.
European Urology|February 21, 2023
Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma PatientsJudikael R Saout, Gwendoline Lecuyer, Simon Léonard, et al.
Environmental Research|November 20, 2022
Persistent organochlorine pesticides in periprostatic adipose tissue from men with prostate cancer: Ethno-geographic variations, association with disease aggressivenessJean-Philippe Antignac, Sandy Figiel, Michèle Pinault, et al.
World Journal of Urology|December 9, 2022
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont, et al.
Urologic Oncology|June 6, 2022
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362Francesco Soria, Ilaria Lucca, Marco Moschini, et al.
Urologic Oncology|November 21, 2017
Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomySouhil Lebdai, Romain Mathieu, Julie Leger, et al.
Urologic Oncology|March 27, 2017
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancerFrancesco Soria, Ilaria Lucca, Marco Moschini, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
The French Journal of Urology|October 11, 2025
Understanding management strategies for metastatic hormone-sensitive prostate cancer: A multidisciplinary survey in FranceAurélien Gobert, Marc-Olivier Timsit, Pierre Blanchard, et al.
The French Journal of Urology|July 7, 2026
Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological AssociationMichael Baboudjian, Eric Barret, Laurent Brureau, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Anthony Chapron, Marie-Astrid Metten, Arnaud Maury, et al.
Journal of Clinical Medicine|January 11, 2022
Overview of the Development and Use of Akt Inhibitors in Prostate CancerAnis Gasmi, Guilhem Roubaud, Charles Dariane, et al.
European Urology|February 21, 2023
Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma PatientsJudikael R Saout, Gwendoline Lecuyer, Simon Léonard, et al.
Environmental Research|November 20, 2022
Persistent organochlorine pesticides in periprostatic adipose tissue from men with prostate cancer: Ethno-geographic variations, association with disease aggressivenessJean-Philippe Antignac, Sandy Figiel, Michèle Pinault, et al.
World Journal of Urology|December 9, 2022
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont, et al.
Urologic Oncology|June 6, 2022
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362Francesco Soria, Ilaria Lucca, Marco Moschini, et al.
Urologic Oncology|November 21, 2017
Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomySouhil Lebdai, Romain Mathieu, Julie Leger, et al.
Urologic Oncology|March 27, 2017
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancerFrancesco Soria, Ilaria Lucca, Marco Moschini, et al.
Pageof 22